Metabolic Reprogramming of Sulfur in Hepatocellular Carcinoma and Sulfane Sulfur-Triggered Anti-Cancer Strategy

被引:14
|
作者
Zhang, Ximing [1 ]
Chen, Mianrong [1 ]
Ni, Xiang [2 ]
Wang, Yingying [3 ]
Zheng, Xue [1 ]
Zhang, Hui [1 ]
Xu, Shi [2 ]
Yang, Chun-tao [1 ]
机构
[1] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou Municipal & Guangdong Prov Key Lab Prot, Affiliated Canc Hosp & Inst, Guangzhou, Peoples R China
[2] Brown Univ, Dept Chem, Providence, RI 02912 USA
[3] Washington State Univ, Dept Chem, Pullman, WA 99164 USA
关键词
bioinformatics; hepatocellular carcinoma; metabolic reprogramming; reactive sulfur species; sulfane sulfur; HYDROGEN-SULFIDE; VITAMIN-B6; METABOLISM; CANCER; PROLIFERATION; BIOLOGY;
D O I
10.3389/fphar.2020.571143
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabolic reprogramming is a cancer hallmark. Although the reprogramming of central carbon has been well documented, the role of sulfur metabolism has been largely overlooked. Additionally, the effects of sulfur are sometimes contradictory in tumorigenesis. In this study, we aimed to investigate the gene expression profile in hepatocellular carcinoma (HCC) and the effects of reactive sulfur species (RSS) on HCC tumor cells. Furthermore, the cell imaging technology was applied to discover some potential anti-cancer compounds. Gene Set Enrichment Analysis (GSEA) of Gene Expression Omnibus (GEO) dataset (GSE102083) revealed that sulfur amino acid-related metabolism and vitamin B(6)binding activity in HCC tissues were downregulated. Calculation of the interaction network identified nine hub genes, among which eight were validated by differential expression and survival analysis in the TCGA_LIHC cohort, and two (CSE and CBS) had the highest enrichment degree. The metabolomics analysis suggested that the hub genes were associated with RSS metabolism including H2S, H2S2, cystine, cysteine, homocysteine, cystathionine, and methionine. The cell viability assay demonstrated that H(2)S(2)had significant anti-cancer effects in HCC SNU398 tumor cells. The cell imaging assay showed that treatment with H(2)S(2)remarkably increased intracellular sulfane sulfur content. On this basis, the anti-cancer activity of some other sulfane sulfur compounds, such as DATS and DADS, was further verified. Lastly, according to the fact that HCC tumor cells preferentially take in cystine due to high expression of SLC7A11 (a cystine/glutamate transporter), persulfided cysteine precursor (PSCP) was tested for its sulfane sulfur release capability and found to selectively inhibit HCC tumor cell viability. Collectively, this study uncovered sulfur metabolism in HCC was reprogrammed, and provided a potential therapeutic strategy for HCC by donating sulfane sulfur.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Establishment of Hepatocellular Carcinoma derived from a cancer stem cell line is characterized by significant metabolic reprogramming
    Cassim, Shamir
    Raymond, Valerie-Ann
    Lacoste, Benoit
    Bilodeau, Marc
    HEPATOLOGY, 2017, 66 : 976A - 976A
  • [42] Phenylboronic acid conjugated to doxorubicin nanocomplexes as an anti-cancer drug delivery system in hepatocellular carcinoma
    Kang, Byung-Yoon
    Hur, Wonhee
    Kim, Sung Min
    Kim, Seonil
    Lee, Junseok
    Tak, Eunyoung
    Kim, Won Jong
    Chun, Ho Jong
    Yoon, Seung Kew
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2021, 34
  • [43] Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma
    Ilamathi, M.
    Santhosh, S.
    Sivaramakrishnan, V.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (22) : 2453 - 2463
  • [44] Synergistic anti-cancer effect of sodium pentaborate pentahydrate, curcumin and piperine on hepatocellular carcinoma cells
    Zehra Omeroglu Ulu
    Nurdan Sena Degirmenci
    Zeynep Busra Bolat
    Fikrettin Sahin
    Scientific Reports, 13 (1)
  • [45] Targeted therapy of magnetic melittin nanoparticles for hepatocellular carcinoma: Preparation, safety and anti-cancer activity
    Su, Yonghua
    Huang, Xueqiang
    Zhang, Huiqing
    Zhang, Jianguo
    Ling, Changquan
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (02) : 561 - 561
  • [46] Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepaatoprotective effects
    Fishman, Pnina
    Stemmer, Salomon M.
    Bareket-Samish, Avital
    Silverman, Michael H.
    Kerns, William D.
    PURINERGIC SIGNALLING, 2023, 19 (03) : 513 - 522
  • [47] Icaritin Exerts Anti-Cancer Effects through Modulating Pyroptosis and Immune Activities in Hepatocellular Carcinoma
    Jiao, Yuanyuan
    Li, Wenqian
    Yang, Wen
    Wang, Mingyu
    Xing, Yaling
    Wang, Shengqi
    BIOMEDICINES, 2024, 12 (08)
  • [48] Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects
    Pnina Fishman
    Salomon M. Stemmer
    Avital Bareket-Samish
    Michael H. Silverman
    William D. Kerns
    Purinergic Signalling, 2023, 19 : 513 - 522
  • [49] Ursolic Acid Suppresses Cholesterol Biosynthesis and Exerts Anti-Cancer Effects in Hepatocellular Carcinoma Cells
    Kim, Geon-Hee
    Kan, Sang-Yeon
    Kang, Hyeji
    Lee, Sujin
    Ko, Hyun Myung
    Kim, Ji Hyung
    Lim, Ji-Hong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (19)
  • [50] Synergistic anti-cancer effect of sodium pentaborate pentahydrate, curcumin and piperine on hepatocellular carcinoma cells
    Ulu, Zehra Omeroglu
    Degirmenci, Nurdan Sena
    Bolat, Zeynep Busra
    Sahin, Fikrettin
    SCIENTIFIC REPORTS, 2023, 13 (01):